The omega-3 index: From biomarker to risk marker to risk factor

Current Atherosclerosis Reports

Volumn 11, Issue 6, 2009, Pages 411-417

  Harris, William S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DOCOSAPENTAENOIC ACID; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACUTE CORONARY SYNDROME; ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FISH; FOOD COMPOSITION; FOOD INTAKE; HEALTH INSURANCE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SECONDARY PREVENTION; STANDARDIZATION;

BIOLOGICAL MARKERS; CORONARY DISEASE; FATTY ACIDS, OMEGA-3; HUMANS; RISK FACTORS;

EID: 70449508666     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-009-0062-2     Document Type: Review

References (52)

1. W.S. Harris C. von Schacky 2004 The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39 212 220 10.1016/j.ypmed.2004.02. 030 1:CAS:528:DC%2BD2cXltVCisL4%3D 15208005 (Pubitemid 38797975)
2. D.S. Siscovick T.E. Raghunathan I. King, et al. 1995 Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest JAMA 274 1363 1367 10.1001/jama.274.17.1363 1:CAS:528:DyaK2MXpsl2ksL0%3D 7563561
3. C.M. Albert H. Campos M.J. Stampfer, et al. 2002 Blood levels of long-chain n-3 fatty acids and the risk of sudden death N Engl J Med 346 1113 1118 10.1056/NEJMoa012918 1:CAS:528:DC%2BD38Xislamtr8%3D 11948270 (Pubitemid 34984601)
4. R.C. Block W.S. Harris K.J. Reid, et al. 2007 EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls Atherosclerosis 197 821 828 10.1016/j.atherosclerosis.2007.07.042 17875307
5. M. Itomura S. Fujioka K. Hamazaki, et al. 2008 Factors influencing EPA+DHA levels in red blood cells in Japan In Vivo 22 131 135 18396795
6. P. Barberger-Gateau C. Raffaitin L. Letenneur, et al. 2007 Dietary patterns and risk of dementia: the Three-City cohort study Neurology 69 1921 1930 10.1212/01.wnl.0000278116.37320.52 1:STN:280:DC%2BD2snntleitg%3D%3D 17998483 (Pubitemid 350100350)
7. E.J. Schaefer V. Bongard A.S. Beiser, et al. 2006 Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study Arch Neurol 63 1545 1550 10.1001/archneur.63.11.1545 17101822 (Pubitemid 44748796)
8. E.W. Chong A.J. Kreis T.Y. Wong, et al. 2008 Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis Arch Ophthalmol 126 826 833 10.1001/archopht.126.6.826 18541848 (Pubitemid 351831334)
9. Q. Sun J. Ma H. Campos, et al. 2007 Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women Am J Clin Nutr 86 74 81 1:CAS:528:DC%2BD2sXotVyntL0%3D 17616765
10. W.S. Harris 2008 The omega-3 index as a risk factor for coronary heart disease Am J Clin Nutr 87 1997S 2002S 1:CAS:528:DC%2BD1cXnslajs7g%3D 18541601
11. Q. Sun J. Ma H. Campos, et al. 2008 Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction Am J Clin Nutr 88 216 223 1:CAS:528:DC%2BD1cXoslyltrw%3D 18614744
12. W.S. Harris W.C. Poston C.K. Haddock 2007 Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events Atherosclerosis 193 1 10 10.1016/j.atherosclerosis.2007.03.018 1:CAS:528:DC%2BD2sXlvFamtro%3D 17507020 (Pubitemid 46776717)
13. M.A. Hlatky P. Greenland D.K. Arnett, et al. 2009 Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2408 2416 10.1161/CIRCULATIONAHA.109. 192278 19364974
14. A.B. Hill 1965 The environment and disease: association or causation? Proc R Soc Med 58 295 300 1:STN:280:DyaF2M%2FovVCmsw%3D%3D 14283879
15. W.S. Harris 2007 International recommendations for consumption of long-chain omega-3 fatty acids J Cardiovasc Med (Hagerstown) 8 Suppl1 S50 S52
16. A. Sekikawa J.D. Curb H. Ueshima, et al. 2008 Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study J Am Coll Cardiol 52 417 424 10.1016/j.jacc.2008.03.047 1:CAS:528:DC%2BD1cXpt1Grs7c%3D 18672160 (Pubitemid 352043837)
17. A.T. Erkkila N.R. Matthan D.M. Herrington, et al. 2006 Higher plasma docosahexaenoic acid is associated with reduced progression of coronary-artery atherosclerosis in women with established coronary artery disease J Lipid Res 47 2814 2819 10.1194/jlr.P600005-JLR200 1:CAS:528:DC%2BD28XhtlSitL7L 16983146 (Pubitemid 44936095)
18. D. Mozaffarian R.N. Lemaitre L.H. Kuller, et al. 2003 Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study Circulation 107 1372 1377 10.1161/01.CIR.0000055315. 79177.16 12642356 (Pubitemid 36350734)
19. R.C. Block W.S. Harris J.V. Pottala 2008 Determinants of blood cell omega-3 fatty acid content Open Biomarkers J 1 1 6 10.2174/1875318300801010001 1:CAS:528:DC%2BD1MXhtFaqu74%3D
20. K. He Y. Song M.L. Daviglus, et al. 2004 Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies Circulation 109 2705 2711 10.1161/01.CIR.0000132503.19410.6B 15184295 (Pubitemid 38737914)
21. H. Iso M. Kobayashi J. Ishihara, et al. 2006 Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I Circulation 113 195 202 10.1161/CIRCULATIONAHA.105.581355 1:CAS:528:DC%2BD28Xis1KjsQ%3D%3D 16401768 (Pubitemid 43754375)
22. G.C. Shearer J.V. Pottala J.A. Spertus, et al. 2009 Red blood cell fatty acid patterns and acute coronary syndrome PLoS ONE 4 e5444 10.1371/journal.pone. 0005444 19421317
23. R.C. Block W.S. Harris K.J. Reid, et al. 2008 Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 156 1117 1123 10.1016/j.ahj.2008.07.014 1:CAS:528:DC%2BD1cXhsVWrs7vL 19033007
24. W.S. Harris J.V. Pottala S.A. Sands, et al. 2007 Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids Am J Clin Nutr 86 1621 1625 1:CAS:528: DC%2BD2sXhsVGhs7fE 18065578
25. D. Mozaffarian E.B. Rimm 2006 Fish intake, contaminants, and human health: evaluating the risks and the benefits JAMA 296 1885 1899 10.1001/jama.296.15.1885 1:CAS:528:DC%2BD28XhtFWmt7%2FF 17047219
26. M.L. Burr A.M. Fehily J.F. Gilbert, et al. 1989 Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 2 757 761 10.1016/S0140-6736(89)90828-3 1:STN:280:DyaL1MzotlOluw%3D%3D 2571009
27. R. Marchioli F. Barzi E. Bomba, et al. 2002 Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 1897 1903 10.1161/01.CIR.0000014682.14181.F2 1:CAS:528:DC%2BD38XktFajtbc%3D 11997274 (Pubitemid 34437615)
28. GISSI-HF investigators 2008 Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 1223 1230 10.1016/S0140- 6736(08)61239-8
29. M. Yokoyama H. Origasa M. Matsuzaki, et al. 2007 Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 1090 1098 10.1016/S0140-6736(07)60527-3 1:CAS:528:DC%2BD2sXjs1Ohtro%3D 17398308 (Pubitemid 46483662)
30. J.K. Schmier N.J. Rachman M.T. Halpern 2006 The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Manag Care 15 43 50 16686171
31. M. Lamotte L. Annemans P. Kawalec, et al. 2006 A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction Herz 3 Suppl 74 82
32. C.M. Albert N.R. Cook J.M. Gaziano, et al. 2008 Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA 299 2027 2036 10.1001/jama.299.17.2027 1:CAS:528:DC%2BD1cXlslanurs%3D 18460663 (Pubitemid 351656584)
33. W.S. Harris D. Mozaffarian M. Lefevre, et al. 2009 Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids J Nutr 139 804S 819S 10.3945/jn.108.101329 1:CAS:528:DC%2BD1MXjslSktbg%3D 19244379
34. W.S. Harris M. Miller A.P. Tighe, et al. 2008 Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives Atherosclerosis 197 12 24 10.1016/j.atherosclerosis.2007.11.008 1:CAS:528:DC%2BD1cXisVSmurY%3D 18160071
35. P.M. Kris-Etherton W.S. Harris L.J. Appel 2002 Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2747 2757 10.1161/01.CIR.0000038493.65177.94 12438303 (Pubitemid 35364932)
36. W. Stillwell S.R. Shaikh M. Zerouga, et al. 2005 Docosahexaenoic acid affects cell signaling by altering lipid rafts Reprod Nutr Dev 45 559 579 10.1051/rnd:2005046 1:CAS:528:DC%2BD2MXht1CmurbP 16188208 (Pubitemid 41511882)
37. R.A. Siddiqui K.A. Harvey G.P. Zaloga 2008 Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health J Nutr Biochem 19 417 437 10.1016/j.jnutbio.2007.07.001 1:CAS:528: DC%2BD1cXntlSrt7g%3D 17904342 (Pubitemid 351783409)
38. A. Leaf C.M. Albert M. Josephson, et al. 2005 Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake Circulation 112 2762 2768 10.1161/CIRCULATIONAHA.105.549527 1:CAS:528:DC%2BD2MXhtFCru7bK 16267249 (Pubitemid 41641669)
39. Farzaneh-Far R, Harris WS, Garg S, et al.: Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2008 Dec 14 (Epub ahead of print).
40. A.A. Amin R.A. Menon K.J. Reid, et al. 2008 Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels Psychosom Med 70 856 862 10.1097/PSY.0b013e318188a01e 1:CAS:528: DC%2BD1cXht1aisLrM 18842751
41. C. Augood U. Chakravarthy I. Young, et al. 2008 Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration Am J Clin Nutr 88 398 406 1:CAS:528:DC%2BD1cXhtVWnu7vJ 18689376
42. T. Kamada T. Yamashita Y. Baba, et al. 1986 Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients Diabetes 35 604 611 10.2337/diabetes.35.5.604 1:STN:280:DyaL287msFChug%3D%3D 3956887
43. W. Stillwell S.R. Wassall 2003 Docosahexaenoic acid: membrane properties of a unique fatty acid Chem Phys Lipids 126 1 27 10.1016/S0009-3084(03)00101-4 1:CAS:528:DC%2BD3sXot1OltL8%3D 14580707 (Pubitemid 37297962)
44. D.W. Ma J. Seo K.C. Switzer, et al. 2004 n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research J Nutr Biochem 15 700 706 10.1016/j.jnutbio.2004.08.002 1:CAS:528:DC%2BD2cXhtVKktrvK 15590275 (Pubitemid 39611369)
45. Q. Li M. Wang L. Tan, et al. 2005 Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts J Lipid Res 46 1904 1913 10.1194/jlr.M500033-JLR200 1:CAS:528:DC%2BD2MXhtVSlur3N 15930520 (Pubitemid 41248487)
46. M. Akbar F. Calderon Z. Wen, et al. 2005 Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival Proc Natl Acad Sci U S A 102 10858 10863 10.1073/pnas.0502903102 1:CAS:528:DC%2BD2MXnvVWjtro%3D 16040805 (Pubitemid 41105957)
47. P.C. Calder 2006 n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases Am J Clin Nutr 83 1505S 1519S 1:CAS:528: DC%2BD28XlvVOltrs%3D 16841861
48. W.L. Blok M.B. Katan J.W. van der Meer 1996 Modulation of inflammation and cytokine production by dietary (n-3) fatty acids J Nutr 126 1515 1533 1:CAS:528:DyaK28XjtlKksbo%3D 8648424
49. A. Leaf J.X. Kang Y.F. Xiao, et al. 2003 Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 2646 2652 10.1161/01.CIR. 0000069566.78305.33 12782616
50. B. London C. Albert M.E. Anderson, et al. 2007 Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop Circulation 116 e320 e335 10.1161/CIRCULATIONAHA.107.712984 1:CAS:528:DC%2BD2sXhtl2isLfF 17768297 (Pubitemid 47360222)
51. M.H. Davidson 2006 Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids Am J Cardiol 98 27i 33i 10.1016/j.amjcard.2005.12.024 1:CAS:528:DC%2BD28XpslWitbk%3D 16919514 (Pubitemid 44223362)
52. R.J. Deckelbaum T.S. Worgall T. Seo 2006 n-3 fatty acids and gene expression Am J Clin Nutr 83 1520S 1525S 1:CAS:528:DC%2BD28XlvVOltrg%3D 16841862